APA

Maksymowych W. P., Dougados M., van der Heijde D., Sieper J., Braun J., Citera G., Van den Bosch F., Logeart I., Wajdula J., Jones H., Marshall L., Bonin R., Pedersen R., Vlahos B., Kotak S. & Bukowski J. F. (20170523). Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study. : Annals of the rheumatic diseases.

Chicago

Maksymowych Walter P, Dougados Maxime, van der Heijde Désirée, Sieper Joachim, Braun Jürgen, Citera Gustavo, Van den Bosch Filip, Logeart Isabelle, Wajdula Joseph, Jones Heather, Marshall Lisa, Bonin Randi, Pedersen Ron, Vlahos Bonnie, Kotak Sameer and Bukowski Jack F. 20170523. Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study. : Annals of the rheumatic diseases.

Harvard

Maksymowych W. P., Dougados M., van der Heijde D., Sieper J., Braun J., Citera G., Van den Bosch F., Logeart I., Wajdula J., Jones H., Marshall L., Bonin R., Pedersen R., Vlahos B., Kotak S. and Bukowski J. F. (20170523). Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study. : Annals of the rheumatic diseases.

MLA

Maksymowych Walter P, Dougados Maxime, van der Heijde Désirée, Sieper Joachim, Braun Jürgen, Citera Gustavo, Van den Bosch Filip, Logeart Isabelle, Wajdula Joseph, Jones Heather, Marshall Lisa, Bonin Randi, Pedersen Ron, Vlahos Bonnie, Kotak Sameer and Bukowski Jack F. Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study. : Annals of the rheumatic diseases. 20170523.